Cytogen


Cytogen is developing, and commercializing a portfolio of oncology products. Caphosol is an approved electrolyte solution for the treatment of oral mucositis and dry mouth that is seen during chemotherapy. Cytogen's specialized sales force also markets Quadramet (for metastatic bone pain), Prostascint (a prostate cancer imaging agent), and Soltamox (liquid tamoxifen).

Cytogen is developing, and commercializing a portfolio of oncology products. Caphosol is an approved electrolyte solution for the treatment of oral mucositis and dry mouth that is seen during chemotherapy. Cytogen's specialized sales force also marke...Show all

Company (Acquired)

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Cytogen $0M Mar 11, 2008

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Cytogen Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Merlin NexusPrivate EquityNew York, New York, United StatesOther Investors
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Slide assembly Jul 15, 2014 Aug 22, 2017 Patent
Microfluidic device and method for isolating target using same Apr 15, 2011 Jun 21, 2016 Patent
Cell collecting device Nov 11, 2016 Application
Cell collecting device May 09, 2016 Application
Chip for preliminary sample evaluation and cell collection Jul 15, 2014 Application